Taking ositinib does not affect the physiological cycle, but may have an effect on women who are preparing for pregnancy, pregnant women, and breastfeeding women. Ocitinib is mainly used for the treatment of adults with metastatic non-small cell lung cancer, and there is no clear evidence that taking ocitinib affects the physiological cycle. Women of childbearing age should avoid pregnancy while using the drug. And the drug is toxic for reproduction, so it is not used for treatment during pregnancy as well as breastfeeding, unless necessary. Adverse reactions such as diarrhea, rash, and dry skin may occur when taking Ossitinib, and the drug is contraindicated in people who are allergic to Ossitinib. It is recommended to use the drug under the supervision of a doctor.